Committee to review evidence for use of medical cannabis in employer plans
Reformulary Group, an independent drug plan management company, announced May 16 the establishment of its Cannabis Formulary Committee, which the company says will review the best available evidence for medical cannabis and provide expert opinions and criteria for its use in specific indications.
Consumption and quantity limits
The committee “will recommend specific medical uses and devel...
by The IIJ Staff May 18, 2018, 1:30 p.m.